Involvement of Metformin and AMPK in the Radioresponse and Prognosis of Luminal Versus Basal-Like Breast Cancer Treated With Radiotherapy

Oncotarget - United States
doi 10.18632/oncotarget.2683
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Basal Markers and Prognosis in Luminal Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2017English

Active Smoking and Risk of Luminal and Basal-Like Breast Cancer Subtypes in the Carolina Breast Cancer Study

Cancer Causes and Control
Cancer ResearchOncology
2016English

SEL1L Stratifies the Prognosis of Breast Cancer Patients Treated With Radiotherapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

The Suppression of DUSP5 Expression Correlates With Paclitaxel Resistance and Poor Prognosis in Basal-Like Breast Cancer

International Journal of Medical Sciences
Medicine
2018English

Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2013English

Triple-Negative Breast Cancer: Clinicopathological Characteristics and Relationship With Basal-Like Breast Cancer

Modern Pathology
Forensic MedicinePathology
2009English

High CD90 (THY-1) Expression Positively Correlates With Cell Transformation and Worse Prognosis in Basal-Like Breast Cancer Tumors

PLoS ONE
Multidisciplinary
2018English

Biomarkers for Basal-Like Breast Cancer

Cancers
Cancer ResearchOncology
2010English

The Oncogenic Role of RhoGAPs in Basal-Like Breast Cancer

2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy